piperacillin has been researched along with pexiganan in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cirioni, O; D'Amato, G; Ghiselli, R; Giacometti, A; Kamysz, W; Lukasiak, J; Mocchegiani, F; Naldoski, P; Orlando, F; Saba, V; Scalise, G; Silvestri, C; Sisti, V | 1 |
Cirioni, O; D'Amato, G; Ghiselli, R; Giacometti, A; Kamysz, W; Mocchegiani, F; Orlando, F; Rocchi, M; Saba, V; Scalise, G; Silvestri, C; Ĺukasiak, J | 1 |
2 other study(ies) available for piperacillin and pexiganan
Article | Year |
---|---|
Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models.
Topics: Abdomen; Amino Acid Sequence; Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Cecum; Colony Count, Microbial; Endotoxins; Escherichia coli; Escherichia coli Infections; Injections, Intraperitoneal; Male; Microbial Sensitivity Tests; Penicillins; Peritonitis; Piperacillin; Rats; Rats, Wistar; Sepsis; Shock, Septic; Tumor Necrosis Factor-alpha | 2004 |
Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Cecum; Drug Therapy, Combination; Endotoxins; Escherichia coli; Escherichia coli Infections; Imipenem; Injections, Intraperitoneal; Limulus Test; Lipopolysaccharides; Male; Piperacillin; Polymyxin B; Rats; Rats, Wistar; Shock, Septic; Time Factors; Tumor Necrosis Factor-alpha | 2005 |